COMPARATIVE CLINICAL STUDY BETWEEN LASHUNA AND SHATAVARI IN MINIMIZING THE RISK OF POSTMENOPAUSAL OSTEOPOROSIS

Phase 1

• Conditions: Health Condition 1: null- postmenopausal osteoporosis

• Registration Number: CTRI/2017/04/008407
• Lead Sponsor: PARUL INSTITUTE OF AYURVEDA

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Women of age group 40-60 years (Perimenopausal ,Menopausal, Post Menopausal age group) presentingoneormore risk factors ofdevelopingOsteoporosis.

-Clinical symptoms of Osteoporosisand laboratoryinvestigations showing boneloss.

-OsteoporoticfemalepatientswhoseBMD(t-score)isequaltoorlessthan-1willbe taken forthe present study.

- Patients diagnosedto beOsteoporoticon the basisof Singhâ??sindex.

- Patients presenting with the classical symptoms of Asthi Kshaya vis-a-via

Osteoporosiswillbetaken for the study.

Exclusion Criteria

BMD â??tâ?? â??score above -1 will be excluded.

• Patients suffering from neoplasm of the bone will be excluded.

•Known cases of Diabetes mellitus, uncontrolled Hypertension, Thyrotoxicosis, Hyper Parathyroidism, Addisonâ??s disease, Pagetâ??s disease, Cushingâ??s syndrome, Tuberculosis of the bone, Osteomalacia, and Chronic Renal, Hepatic and Cardiac Failure will be excluded.

•Rheumatoid Arthritis, Gouty Arthritis and any long-standing systemic disorder will be excluded.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
reduces the post menopausal riskof osteoporosisTimepoint: reduces the post menopausal riskof osteoporosis

Secondary Outcome Measures

Name	Time	Method
reduce pain,improves the quality of lifeTimepoint: 12 weeks